vs
Planet Labs PBC（PL）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.4倍（$81.3M vs $60.1M），Planet Labs PBC净利率更高（-72.8% vs -92.6%，领先19.7%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 32.6%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 17.5%）
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
PL vs RYTM — 直观对比
营收规模更大
PL
是对方的1.4倍
$60.1M
营收增速更快
RYTM
高出51.2%
32.6%
净利率更高
PL
高出19.7%
-92.6%
两年增速更快
RYTM
近两年复合增速
17.5%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $81.3M | $60.1M |
| 净利润 | $-59.2M | $-55.6M |
| 毛利率 | 57.3% | 88.1% |
| 营业利润率 | -22.6% | -87.1% |
| 净利率 | -72.8% | -92.6% |
| 营收同比 | 32.6% | 83.8% |
| 净利润同比 | -194.7% | — |
| 每股收益（稀释后） | $-0.19 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $81.3M | $57.3M | ||
| Q3 25 | $73.4M | $51.3M | ||
| Q2 25 | $66.3M | $48.5M | ||
| Q1 25 | $61.6M | $32.7M | ||
| Q4 24 | $61.3M | $41.8M | ||
| Q3 24 | $61.1M | $33.3M | ||
| Q2 24 | $60.4M | $29.1M |
净利润PLRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $-59.2M | $-47.5M | ||
| Q3 25 | $-22.6M | $-52.9M | ||
| Q2 25 | $-12.6M | $-46.6M | ||
| Q1 25 | $-35.2M | $-49.5M | ||
| Q4 24 | $-20.1M | $-43.3M | ||
| Q3 24 | $-38.7M | $-43.6M | ||
| Q2 24 | $-29.3M | $-32.3M |
毛利率PLRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | 57.3% | 91.6% | ||
| Q3 25 | 57.6% | 89.3% | ||
| Q2 25 | 55.2% | 88.6% | ||
| Q1 25 | 62.1% | 88.8% | ||
| Q4 24 | 61.2% | 90.9% | ||
| Q3 24 | 52.9% | 88.5% | ||
| Q2 24 | 52.4% | 89.9% |
营业利润率PLRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | -22.6% | -82.2% | ||
| Q3 25 | -24.5% | -102.6% | ||
| Q2 25 | -34.4% | -93.4% | ||
| Q1 25 | -31.5% | -143.7% | ||
| Q4 24 | -36.9% | -98.6% | ||
| Q3 24 | -64.8% | -132.0% | ||
| Q2 24 | -57.2% | -139.2% |
净利率PLRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | -72.8% | -83.0% | ||
| Q3 25 | -30.8% | -103.1% | ||
| Q2 25 | -19.1% | -96.1% | ||
| Q1 25 | -57.1% | -151.4% | ||
| Q4 24 | -32.8% | -103.6% | ||
| Q3 24 | -63.3% | -131.2% | ||
| Q2 24 | -48.5% | -110.9% |
每股收益（稀释后）PLRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-0.19 | $-0.73 | ||
| Q3 25 | $-0.07 | $-0.82 | ||
| Q2 25 | $-0.04 | $-0.75 | ||
| Q1 25 | $-0.12 | $-0.81 | ||
| Q4 24 | $-0.07 | $-0.71 | ||
| Q3 24 | $-0.13 | $-0.73 | ||
| Q2 24 | $-0.10 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $443.3M | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $349.6M | $122.9M |
| 总资产 | $1.1B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $443.3M | $388.9M | ||
| Q3 25 | $181.1M | $416.1M | ||
| Q2 25 | $133.5M | $291.0M | ||
| Q1 25 | $118.0M | $314.5M | ||
| Q4 24 | $139.0M | $320.6M | ||
| Q3 24 | $148.3M | $298.4M | ||
| Q2 24 | $107.4M | $319.1M |
股东权益PLRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $349.6M | $139.1M | ||
| Q3 25 | $435.7M | $148.8M | ||
| Q2 25 | $444.8M | $-11.9M | ||
| Q1 25 | $441.3M | $18.9M | ||
| Q4 24 | $464.6M | $21.7M | ||
| Q3 24 | $473.2M | $11.2M | ||
| Q2 24 | $500.3M | $39.3M |
总资产PLRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $1.1B | $480.2M | ||
| Q3 25 | $696.4M | $506.9M | ||
| Q2 25 | $658.4M | $372.7M | ||
| Q1 25 | $633.8M | $386.7M | ||
| Q4 24 | $630.8M | $392.3M | ||
| Q3 24 | $658.4M | $363.6M | ||
| Q2 24 | $674.6M | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.6M | — |
| 自由现金流经营现金流 - 资本支出 | $1.9M | — |
| 自由现金流率自由现金流/营收 | 2.3% | — |
| 资本支出强度资本支出/营收 | 32.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.7M | — |
8季度趋势，按日历期对齐
经营现金流PLRYTM
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $-25.4M | ||
| Q3 25 | $67.8M | $-26.6M | ||
| Q2 25 | $17.3M | $-23.3M | ||
| Q1 25 | $-6.3M | $-40.4M | ||
| Q4 24 | $4.1M | $-18.8M | ||
| Q3 24 | $-7.9M | $-25.2M | ||
| Q2 24 | $-4.3M | $-29.1M |
自由现金流PLRYTM
| Q1 26 | — | — | ||
| Q4 25 | $1.9M | — | ||
| Q3 25 | $47.5M | — | ||
| Q2 25 | $9.2M | — | ||
| Q1 25 | $-17.9M | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $-23.0M | — | ||
| Q2 24 | $-14.2M | — |
自由现金流率PLRYTM
| Q1 26 | — | — | ||
| Q4 25 | 2.3% | — | ||
| Q3 25 | 64.7% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | -29.1% | — | ||
| Q4 24 | -5.8% | — | ||
| Q3 24 | -37.6% | — | ||
| Q2 24 | -23.6% | — |
资本支出强度PLRYTM
| Q1 26 | — | — | ||
| Q4 25 | 32.9% | — | ||
| Q3 25 | 27.6% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 18.9% | — | ||
| Q4 24 | 12.5% | — | ||
| Q3 24 | 24.8% | — | ||
| Q2 24 | 16.4% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
RYTM
暂无分部数据
